DeDora Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $568K | Sell |
1,133
-4
| -0.4% | -$1.92K | 0.12% | 82 |
|
|
2026
Q1 | $559K | Sell |
1,137
-14
| -1% | -$7.6K | 0.14% | 78 |
|
|
2025
Q4 | $667K | Hold |
1,151
| – | – | 0.16% | 76 |
|
|
2025
Q3 | $558K | Hold |
1,151
| – | – | 0.13% | 78 |
|
|
2025
Q2 | $467K | Hold |
1,151
| – | – | 0.12% | 86 |
|
|
2025
Q1 | $573K | Sell |
1,151
-17
| -1% | -$9.21K | 0.17% | 77 |
|
|
2024
Q4 | $608K | Sell |
1,168
-7
| -0.6% | -$3.85K | 0.17% | 75 |
|
|
2024
Q3 | $727K | Sell |
1,175
-13
| -1% | -$7.7K | 0.2% | 72 |
|
|
2024
Q2 | $657K | Sell |
1,188
-21
| -2% | -$12K | 0.2% | 72 |
|
|
2024
Q1 | $703K | Sell |
1,209
-500
| -29% | -$281K | 0.22% | 72 |
|
|
2023
Q4 | $907K | Buy |
1,709
+3
| +0.2% | +$1.45K | 0.32% | 59 |
|
|
2023
Q3 | $864K | Buy |
1,706
+152
| +10% | +$81K | 0.34% | 58 |
|
|
2023
Q2 | $811K | Sell |
1,554
-63
| -4% | -$34K | 0.31% | 64 |
|
|
2023
Q1 | $932K | Buy |
1,617
+108
| +7% | +$60.9K | 0.4% | 59 |
|
|
2022
Q4 | $831K | Buy |
1,509
+58
| +4% | +$30.7K | 0.39% | 58 |
|
|
2022
Q3 | $736K | Buy |
1,451
+37
| +3% | +$20.7K | 0.38% | 60 |
|
|
2022
Q2 | $768K | Buy |
1,414
+13
| +0.9% | +$7.16K | 0.39% | 59 |
|
|
2022
Q1 | $828K | Buy |
+1,401
| New | +$805K | 0.33% | 61 |
|
|
2021
Q4 | – | Sell |
-1,405
| Closed | -$803K | – | 99 |
|
|
2021
Q3 | $803K | Buy |
1,405
+60
| +4% | +$32.9K | 0.35% | 57 |
|
|
2021
Q2 | $678K | Buy |
1,345
+53
| +4% | +$25K | 0.3% | 63 |
|
|
2021
Q1 | $590K | Sell |
1,292
-29
| -2% | -$13.8K | 0.28% | 65 |
|
|
2020
Q4 | $615K | Sell |
1,321
-35
| -3% | -$16.4K | 0.3% | 64 |
|
|
2020
Q3 | $599K | Sell |
1,356
-8
| -0.6% | -$3.31K | 0.33% | 62 |
|
|
2020
Q2 | $494K | Sell |
1,364
-2,293
| -63% | -$769K | 0.3% | 64 |
|
|
2020
Q1 | $1.04M | Buy |
3,657
+21
| +0.6% | +$6.62K | 0.78% | 38 |
|
|
2019
Q4 | $1.18M | Sell |
3,636
-105
| -3% | -$31.8K | 0.71% | 38 |
|
|
2019
Q3 | $1.09M | Buy |
3,741
+801
| +27% | +$229K | 0.75% | 40 |
|
|
2019
Q2 | $863K | Buy |
+2,940
| New | +$810K | 0.61% | 45 |
|
|
2019
Q1 | – | Sell |
-3,719
| Closed | -$832K | – | 90 |
|
|
2018
Q4 | $832K | Buy |
3,719
+89
| +2% | +$20.9K | 0.74% | 38 |
|
|
2018
Q3 | $886K | Buy |
3,630
+1,211
| +50% | +$279K | 0.67% | 40 |
|
|
2018
Q2 | $501K | Buy |
2,419
+65
| +3% | +$13.8K | 0.39% | 54 |
|
|
2018
Q1 | $486K | Buy |
2,354
+151
| +7% | +$31.7K | 0.4% | 52 |
|
|
2017
Q4 | $418K | Buy |
+2,203
| New | +$422K | 0.35% | 54 |
|
Other funds holding TMO
RG
VAM
DeDora Capital's TMO Position: Q2 2026 in Review
DeDora Capital reduced its Thermo Fisher Scientific (TMO) stake by 0.35% in Q2 2026, selling an estimated $1.92K and leaving 1,133 shares worth $568K. The position accounts for 0.12% of the portfolio, ranked #82.
DeDora Capital first reported a position in TMO in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.18M in Q4 2019. 1,512 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- DeDora Capital held 1,133 shares of Thermo Fisher Scientific worth $568K as of Q2 2026.
- DeDora Capital sold 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
- Thermo Fisher Scientific made up 0.12% of DeDora Capital's portfolio in Q2 2026, its #82 holding.
- DeDora Capital first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 33 quarters since.
- DeDora Capital's Thermo Fisher Scientific position peaked at $1.18M in Q4 2019.
- 1,512 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on DeDora Capital's 13F filing for Q2 2026, filed 13 Jul 2026.